Logo image of VNE

Veoneer Inc (VNE) Stock Fundamental Analysis

NYSE:VNE - New York Stock Exchange, Inc. - Common Stock

36.95  +0.07 (+0.19%)

After market: 36.96 +0.01 (+0.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VNE. VNE was compared to 83 industry peers in the Automobile Components industry. VNE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, VNE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VNE had negative earnings in the past year.
VNE Yearly Net Income VS EBIT VS OCF VS FCFVNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -100M -200M -300M -400M -500M

1.2 Ratios

Industry RankSector Rank
ROA -22%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VNE Yearly ROA, ROE, ROICVNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -10 -20 -30 -40

1.3 Margins

Industry RankSector Rank
OM -20.46%
PM (TTM) -23.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VNE Yearly Profit, Operating, Gross MarginsVNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20 -30

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, VNE has more shares outstanding
Compared to 1 year ago, VNE has an improved debt to assets ratio.
VNE Yearly Shares OutstandingVNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
VNE Yearly Total Debt VS Total AssetsVNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.01 indicates that VNE is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.27 indicates that VNE is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.01
ROIC/WACCN/A
WACCN/A
VNE Yearly LT Debt VS Equity VS FCFVNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M -500M 1B 1.5B

2.3 Liquidity

VNE has a Current Ratio of 1.67. This is a normal value and indicates that VNE is financially healthy and should not expect problems in meeting its short term obligations.
VNE has a Quick Ratio of 1.33. This is a normal value and indicates that VNE is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.33
VNE Yearly Current Assets VS Current LiabilitesVNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.05% over the past year.
VNE shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.77%.
The Revenue has been decreasing by -5.67% on average over the past years.
EPS 1Y (TTM)20.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.1%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y-9.4%
Revenue growth 5Y-5.67%
Sales Q2Q%-1.32%

3.2 Future

The Earnings Per Share is expected to grow by 15.01% on average over the next years. This is quite good.
Based on estimates for the next years, VNE will show a quite strong growth in Revenue. The Revenue will grow by 18.15% on average per year.
EPS Next Y45.31%
EPS Next 2Y32.27%
EPS Next 3Y27.67%
EPS Next 5Y15.01%
Revenue Next Year26.64%
Revenue Next 2Y22.93%
Revenue Next 3Y19.71%
Revenue Next 5Y18.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VNE Yearly Revenue VS EstimatesVNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
VNE Yearly EPS VS EstimatesVNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VNE Price Earnings VS Forward Price EarningsVNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -17.53
VNE Per share dataVNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

VNE's earnings are expected to grow with 27.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.27%
EPS Next 3Y27.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Veoneer Inc

NYSE:VNE (3/31/2022, 8:04:26 PM)

After market: 36.96 +0.01 (+0.03%)

36.95

+0.07 (+0.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-02 2022-02-02/bmo
Earnings (Next)04-27 2022-04-27/bmo
Inst Owners1.11%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap4.14B
Analysts54
Price Target34 (-7.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.5
P/FCF N/A
P/OCF N/A
P/B 4.85
P/tB N/A
EV/EBITDA -17.53
EPS(TTM)-3.43
EYN/A
EPS(NY)-1.88
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.79
BVpS7.61
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -20.46%
PM (TTM) -23.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.33
Altman-Z 2.01
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.1%
EPS Next Y45.31%
EPS Next 2Y32.27%
EPS Next 3Y27.67%
EPS Next 5Y15.01%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y-9.4%
Revenue growth 5Y-5.67%
Sales Q2Q%-1.32%
Revenue Next Year26.64%
Revenue Next 2Y22.93%
Revenue Next 3Y19.71%
Revenue Next 5Y18.15%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A